Commercial Vehicles

Business

Financial Institutions Caps 'Strong' 2025 with Robust Earnings, Eyes Growth from Micron-Led Upstate NY Boom

Financial Institutions (FISI) reported solid Q4 and full-year 2025 results, beating guidance on key profitability metrics. Management highlighted disciplined loan growth, a strengthened capital position, and strategic shifts, while pointing to long-term opportunities from major industrial investments in its Upstate New York footprint.

Jan 30, 2026

Business

Allegro MicroSystems Secures $285 Million in Long-Term Debt to Fuel Growth Amid Lofty Valuation

Allegro MicroSystems (ALGM) has restructured its credit facilities, securing $285 million in new term loans maturing in 2030. The move provides the semiconductor firm with fresh capital for corporate initiatives as it navigates a capital-intensive sector while maintaining a premium market valuation.

Jan 30, 2026

Business

Drax Inks Major 10-Year Deal to Bolster UK Grid with 250MW Battery Storage

Energy giant Drax has secured a decade-long tolling agreement with Fidra Energy for a new 250MW battery storage system in Nottinghamshire, marking a capital-light expansion of its flexible generation portfolio as the UK races to decarbonise.

Jan 30, 2026

Business

Rockwell Automation Powers Saudi Arabia's First EV Factory, Bolstering Its Industrial Software Ambitions

Rockwell Automation expands its partnership with Lucid Motors, deploying its FactoryTalk MES software and training programs at Saudi Arabia's inaugural electric vehicle production hub. The move aligns with the Kingdom's Vision 2030, positioning Rockwell as a key player in the region's high-tech manufacturing transformation.

Jan 30, 2026

Business

Analysts Revise Target for Invesco Mortgage Capital, Signaling Shift in Market Sentiment

A revised price target for Invesco Mortgage Capital (IVR) is prompting investors to reassess the mortgage REIT's trajectory amid evolving interest rate expectations and housing market dynamics.

Jan 30, 2026

World

Historic Tunisian Village of Sidi Bou Said Faces Existential Threat Following Catastrophic Floods

The iconic blue-and-white village of Sidi Bou Said, a jewel of Tunisia's cultural heritage, is grappling with severe landslide risks after unprecedented rainfall. Experts warn that urgent conservation measures are needed to prevent irreversible damage to its historic slopes, as climate change and urban pressure compound the crisis.

Jan 30, 2026

Business

Guggenheim More Than Doubles Erasca Price Target to $12 on Clinical Progress and Pipeline Updates

Erasca Inc. (ERAS) sees its price target raised from $5 to $12 by Guggenheim, following promising clinical data for its lead oncology candidates and updated financial models. The move comes amid a series of positive analyst revisions for the clinical-stage biopharma firm.

Jan 30, 2026

Business

Alumis Soars as Psoriasis Drug Hits All Phase 3 Goals, Drawing Bullish Analyst Praise

Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.

Jan 30, 2026

Business

Analyst Bullish on BrightSpire Capital, Citing Strong Liquidity to Fuel 2026 Growth

B.Riley initiates coverage on BrightSpire Capital (BRSP) with a Buy rating, highlighting its robust cash position and improved credit quality as key drivers for future loan originations, while its stock trades at a discount to book value.

Jan 30, 2026

Business

Innodata Secures Key U.S. Missile Defense Agency Contract, Bolstering AI and Data Services Portfolio

Innodata Inc. (NASDAQ: INOD), a data engineering and AI services firm, has been awarded a place on a critical U.S. Missile Defense Agency contract vehicle, positioning it for future task orders in defense technology development and fueling analyst optimism for its 2026 growth trajectory.

Jan 30, 2026

Business

LifeSci Capital Boosts Price Target on Olema Pharmaceuticals, Citing Promising Breast Cancer Drug Pipeline

LifeSci Capital reaffirms its Buy rating on Olema Pharmaceuticals (OLMA) and raises its price target to $45, following bullish analyst sentiment on the company's lead drug candidate, Palazestrant, for ER+/HER2- breast cancer.

Jan 30, 2026

Business

Immunocore Gains Analyst Backing as Late-Stage Trials Loom

Immunocore Holdings (NASDAQ: IMCR) has drawn renewed bullish sentiment from analysts at H.C. Wainwright and UBS, who highlight the stock's potential as key Phase 3 trial data for its cancer immunotherapies approaches later this decade.

Jan 30, 2026

Business

Truist Trims Tesla Target to $438, Maintains Hold as AI Pivot Weighs on Margins

Truist Securities has slightly lowered its price target on Tesla shares to $438, citing the significant capital expenditure required for the automaker's aggressive shift towards AI and robotics, despite a solid Q4 performance.

Jan 30, 2026

Business

U.S. Regulators and Lawmakers Signal Major Shift Toward Crypto Framework

In a landmark day for digital asset policy, U.S. regulators unveiled a coordinated initiative while a key Senate committee advanced market structure legislation, signaling a potential end to years of regulatory uncertainty.

Jan 30, 2026

World

Mozambique Flood Crisis Deepens: UN Warns of Overcrowded Shelters, Pleads for Urgent Aid

As severe flooding displaces hundreds of thousands in Mozambique, the UN raises alarms over dangerously overcrowded temporary shelters and a critical funding shortfall, warning of heightened risks for vulnerable populations.

Jan 30, 2026

Business

Compass Point Raises Price Target on Invesco Mortgage Capital, Sees Opportunity in Wide Spreads

Analyst firm Compass Point reiterates its Buy rating on Invesco Mortgage Capital Inc. (IVR), increasing its price target to $9.50, citing attractive mortgage spreads as a key catalyst for the REIT's potential book value growth.

Jan 30, 2026

World

Mediawan Strikes Deal to Acquire Peter Chernin's North Road, Forging a Global Independent Studio Giant

The acquisition, set to finalize in early 2026 pending approvals, will merge European and American production powerhouses into an entity overseeing nearly 100 companies across 15 countries.

Jan 30, 2026

World

Rare earth power: can Europe ever escape its dependency on China?

Europe relies on China for the rare earth elements essential in transition technologies, but it's making a late bid to end dependency.

Jan 30, 2026

Business

Jim Cramer Bullish on Texas Instruments, Citing Strong Execution Amid Mixed Earnings

CNBC's Jim Cramer highlights Texas Instruments (TXN) for its operational strength, as the chipmaker navigates a challenging market with better-than-expected guidance and analyst optimism.

Jan 30, 2026

Business

Medtronic Doubles Down on Heart Rhythm and Outpatient Care with European Approval and Expanded Partnership

Medtronic secures a key European regulatory nod for its latest pulsed field ablation catheter while deepening its collaboration with Mindray, signaling a strategic push into high-growth areas of cardiac care and ambulatory surgery.

Jan 30, 2026